IntegraGen's mission is to translate molecular research to clinical practice through the identification of novel genetic biomarkers and the subsequent commercialization of molecular diagnostic tests based on these discoveries. The company also strives to be a leader in providing cutting edge genomic services to academic researchers and life sciences companies based on the Company's technological expertise and scientific know how.
IntegraGen was founded in 2000 and is headquartered in Évry, FR
Key People at IntegraGen
Chairman and Chief Executive Officer
Laurence Riot Lamotte
Chief Financial Officer
Vice President of R&D and Medical Affairs
Director of Genomics
Sales and Marketing Director, Services and Arrays
Closing share price
IntegraGen's current market capitalization is €16.9 M.